Cargando…

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms

BACKGROUND: Although re-assessment of proliferative activity by K67 evaluation during the course of neuroendocrine neoplasms (NENs) is recommended in selected patients, its impact on patients’ management is not clear due to the lack of data supporting this practice. AIM: To investigate Ki67 change a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panzuto, Francesco, Cicchese, Noemi, Partelli, Stefano, Rinzivillo, Maria, Capurso, Gabriele, Merola, Elettra, Manzoni, Marco, Pucci, Eugenio, Iannicelli, Elsa, Pilozzi, Emanuela, Rossi, Michele, Doglioni, Claudio, Falconi, Massimo, Delle Fave, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482443/ https://www.ncbi.nlm.nih.gov/pubmed/28644861 http://dx.doi.org/10.1371/journal.pone.0179445

Ejemplares similares

Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis
por: Merola, Elettra, et al.
Publicado: (2017)

Novel Molecular Targets for the Treatment of Gastroenteropancreatic Endocrine Tumors: Answers and Unsolved Problems
por: Capurso, Gabriele, et al.
Publicado: (2012)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
por: Pergolini, I., et al.
Publicado: (2019)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
por: Andreasi, Valentina, et al.
Publicado: (2019)

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center
por: Magi, Ludovica, et al.
Publicado: (2019)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
por: Calabretta, Sara, et al.
Publicado: (2015)

Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells
por: Passacantilli, Ilaria, et al.
Publicado: (2017)

Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia
por: Marasco, Matteo, et al.
Publicado: (2023)

Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning
por: Niazi, Muhammad Khalid Khan, et al.
Publicado: (2018)

The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms
por: Pelosi, Giuseppe, et al.
Publicado: (2021)

Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
por: Massironi, Sara, et al.
Publicado: (2022)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study
por: Shi, Huiying, et al.
Publicado: (2018)

The assessment of Ki-67 for prognosis of gastroenteropancreatic neuroendocrine neoplasm patients: a systematic review and meta-analysis
por: Tao, Zhiwei, et al.
Publicado: (2023)

Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function
por: Zamponi, Virginia, et al.
Publicado: (2022)

CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors
por: Caruso, Damiano, et al.
Publicado: (2022)

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future
por: La Rosa, Stefano
Publicado: (2023)

Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment
por: Piciucchi, Matteo, et al.
Publicado: (2015)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors
por: Berardi, Rossana, et al.
Publicado: (2017)

Magnetic Resonance Cholangiopancreatography with Secretin Stimulation in the Diagnosis of Intraductal Papillary Mucinous Neoplasm: A Paradigmatic Case Report
por: Iannicelli, Elsa, et al.
Publicado: (2014)

Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring
por: Luchini, Claudio, et al.
Publicado: (2022)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues
por: Xing, Yan, et al.
Publicado: (2017)

Diagnostic Accuracy of ki-67 Labeling Index in Endoscopic Ultrasonography-Fine-Needle Aspiration Cytology and Biopsy of Pancreatic Neuroendocrine Neoplasms
por: Pyo, Jung-Soo, et al.
Publicado: (2023)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Association of smoking, p53 and Ki-67 immunomarkers with bladder neoplasms in tribal region of India
por: Vaishnav, Mitsu, et al.
Publicado: (2022)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic
por: Pereira, Rodrigo Storti, et al.
Publicado: (2013)

Endoscopy-guided ablation of pancreatic lesions: Technical possibilities and clinical outlook
por: Signoretti, Marianna, et al.
Publicado: (2017)

Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review
por: Panzuto, Francesco, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects
por: Neubauer, Elisa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ic4nko4o7a3dsrjoa1rj89d47v